Toxicoproteomics -- a new preclinical tool (Q34578614)

3 August 2017

1 reference

title

Toxicoproteomics -- a new preclinical tool (English)

1 reference

3 August 2017

Lasantha R Bandara

1 reference

3 August 2017

Sandy Kennedy

series ordinal

1 reference

3 August 2017

publication date

1 April 2002

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

411-418

1 reference

Proteome and proteomics: new technologies, new concepts, and new words

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Proteomics: quantitative and physical mapping of cellular proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Mass spectrometry for protein and peptide characterisation.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Proteomic profiling from human samples: the body fluid alternative

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

The principles and practice of toxigenomics: applications and opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Advances in molecular toxicology-towards understanding idiosyncratic drug toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Simultaneous measurement of hundreds of liver proteins: application in assessment of liver function

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

The hepatocarcinogen methapyrilene but not the analog pyrilamine induces sustained hepatocellular replication and protein alterations in F344 rats in a 13-week feed study

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Changes in the liver protein pattern of female Wistar rats treated with the hypoglycemic agent SDZ PGU 693.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

The effects of peroxisome proliferators on protein abundances in mouse liver

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Two-dimensional database of mouse liver proteins: changes in hepatic protein levels following treatment with acetaminophen or its nontoxic regioisomer 3-acetamidophenol

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Cyclosporine A decreases the protein level of the calcium-binding protein calbindin-D 28kDa in rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

New insights into cyclosporine A nephrotoxicity by proteome analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

An integrated proteomic approach to studying glomerular nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Proteomic analysis of the renal effects of simulated occupational jet fuel exposure

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Alterations in rabbit kidney protein expression following lead exposure as analyzed by two-dimensional gel electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Retrospective analysis of the safety of Herceptin immunotherapy in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7 g/m(2)) cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Cardiovascular proteomics: evolution and potential

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Application of proteomics to the study of cardiovascular biology

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Protein changes observed in pacing-induced heart failure using two-dimensional electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Identification and characterization of heat shock protein 27 protein species in human myocardial two‐dimensional electrophoresis patterns

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Proteomic analysis of differential protein expression in primary hepatocytes induced by EGF, tumour necrosis factor alpha or the peroxisome proliferator nafenopin.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Two-dimensional gel electrophoresis: a powerful method to elucidate cellular responses to toxic compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

A protein expression database for the molecular pharmacology of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

An information-intensive approach to the molecular pharmacology of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

New active substances authorized in the United Kingdom between 1972 and 1994

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Protein biochips for differential profiling

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Protein and antibody arrays and their medical applications.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Arrays for protein expression profiling: towards a viable alternative to two-dimensional gel electrophoresis?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Mass spectrometry meets chip technology: a new proteomic tool in cancer research?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Integrated genomic and proteomic analyses of a systematically perturbed metabolic network

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Application of genomics to the definition of the molecular basis for toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Gene expression microarray data analysis for toxicology profiling

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Pharmacogenetics and adverse drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

Genetic susceptibility to adverse drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902211-0

7 January 2021

10.1016/S1359-6446(02)02211-0

Identifiers

DOI

1 reference

3 August 2017

1 reference